- Release Date: 26/11/15 11:20
- Summary: GENERAL: BLT: Preliminary Results for BLIS probiotic trial
- Price Sensitive: No
- Download Document 664B
BLT 26/11/2015 11:20 GENERAL NOT PRICE SENSITIVE REL: 1120 HRS BLIS Technologies Limited GENERAL: BLT: Preliminary Results for BLIS probiotic trial Preliminary results from a field trial in the Eastern Bay of Plenty using BLIS K12 probiotic presented to the Paediatric Society of New Zealand yesterday indicated that a one month course of BLIS K12 probiotic achieves a useful, greater decrease in both Group A Streptococcal (GAS) carriage and GAS sore throats than antibiotics alone. Further analysis of the results are being undertaken and presented early next year. Peter Fennessy Chairman End CA:00274150 For:BLT Type:GENERAL Time:2015-11-26 11:20:37
- Forums
- NZX - By Stock
- Ann: GENERAL: BLT: Preliminary Results for BLIS probiotic trial
Ann: GENERAL: BLT: Preliminary Results for BLIS probiotic trial
Featured News
Add BLT (NZSX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.002(10.0%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
2.0¢ | 2.2¢ | 2.0¢ | $19.32K | 903.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 367750 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 22269 | 0 |
Last trade - 13.00pm 27/08/2024 (20 minute delay) ? |
Featured News
BLT (NZSX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online